SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Patients and methods: The gene expression and protein levels of SKP2 were determined using quantitative RT-PCR and ELISA in 100 newly diagnosed CML patients and 100 healthy subjects.